<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02532894</url>
  </required_header>
  <id_info>
    <org_study_id>214/552-31/4</org_study_id>
    <nct_id>NCT02532894</nct_id>
  </id_info>
  <brief_title>Effects of E-smoke on Levels of Endothelial Progenitor Cells and Microparticles in Healthy Volunteers</brief_title>
  <acronym>ESMOKE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We plan to investigate the acute effects of inhaling e-cigarette vapor on cell function
      measured by microvesicles and endothelial progenitor cells. Micro vesicles are released upon
      either activation or apoptosis from different cell types such as platelets, leucocytes and
      endothelial cell. Endothelial progenitor cells are a type of stem cells that circulate in the
      blood with the ability to differentiate to endothelial cells. Endothelial progenitor cells
      are inversely correlated to cardiovascular risk factors.

      As a secondary endpoint we plan to investigate exhaled nitric oxide - a common inflammation
      marker used in asthmatic patients - after inhalation of electronic cigarette vapor.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in number of endothelial progenitor cells</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in number of micro vesicles</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in exhaled nitric oxide</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Esmoke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inhaling e-cigarette vapor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electronic cigarette</intervention_name>
    <description>Inhaling e-cigarette vapor</description>
    <arm_group_label>Esmoke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects

          -  sporadic cigarette smoking (&lt;9 cigarettes per month)

        Exclusion Criteria:

          -  Any form of cardiovascular disease

          -  Any form of pulmonary disease like asthma or COPD

          -  Any form of systemic or chronic disorder like rheumatologic or metabolic diseases.

          -  Active allergy within 4 weeks of the study

          -  Symptoms of infection or inflammation within 4 weeks of the study

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magnus Lundbäck, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institutionen för kliniska vetenskaper, Danderyds sjukhus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institutionen för kliniska vetenskaper, Danderyds sjukhus</name>
      <address>
        <city>Danderyd</city>
        <state>Stockholm</state>
        <zip>18288</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2015</study_first_submitted>
  <study_first_submitted_qc>August 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2015</study_first_posted>
  <last_update_submitted>August 25, 2015</last_update_submitted>
  <last_update_submitted_qc>August 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Magnus Lundbäck</investigator_full_name>
    <investigator_title>MD, PhD,</investigator_title>
  </responsible_party>
  <keyword>endothelial dysfunction</keyword>
  <keyword>microvesicles</keyword>
  <keyword>endothelial progenitor cells</keyword>
  <keyword>electronic cigarettes</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

